Cargando…
Potential Predictors of Cardiovascular Risk Improvement in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A Pivotal Study of Factors Associated with Carotid Intima–Media Thickness Reduction
INTRODUCTION: Hidradenitis suppurativa (HS) has been linked to higher cardiovascular risk (CVR) due to its inflammatory burden. There is little evidence on how biologic treatment could modify the cardiovascular risk of patients with HS. The aims of the present study were to explore the modification...
Autores principales: | Sánchez-Díaz, Manuel, Salvador-Rodríguez, Luis, Cuenca-Barrales, Carlos, Arias-Santiago, Salvador, Molina-Leyva, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984601/ https://www.ncbi.nlm.nih.gov/pubmed/36787042 http://dx.doi.org/10.1007/s13555-023-00898-z |
Ejemplares similares
-
Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis Suppurativa
por: Montero-Vilchez, Trinidad, et al.
Publicado: (2022) -
Neoadjuvant Biologic Therapy in the Surgical Management of Patients with Hidradenitis Suppurativa: A Cohort Study
por: SALVADOR-RODRIGUEZ, Luis, et al.
Publicado: (2020) -
Cumulative Inflammation and HbA1c Levels Correlate with Increased Intima-Media Thickness in Patients with Severe Hidradenitis Suppurativa
por: Sánchez-Díaz, Manuel, et al.
Publicado: (2021) -
The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study
por: Montero-Vilchez, Trinidad, et al.
Publicado: (2021) -
Sexual Dysfunction and Quality of Life in Patients with Hidradenitis Suppurativa and Their Partners
por: Cuenca-Barrales, Carlos, et al.
Publicado: (2022)